WORLDTECHInjective Pitches Tokenized Asset Plumbing to US Regulators in Washington
Injective CEO Eric Chen met officials from the White House, the Securities and Exchange Commission and the Commodity Futures Trading Commission in October 2026, according to Crypto Briefing. The agenda was advancing regulated onchain finance in the United States, and the company has not disclosed specific outcomes.
What Injective brought to the table
The discussions centred on two linked themes. The first concerned the company's own regulatory standing: in August 2026 the SEC registered Injective as a transfer agent, the role that keeps the official books recording who owns which securities. With that status, the company can maintain ownership records for tokenized securities, which institutional players need before they move real money onchain.
The second theme was the tokenization of real-world assets, known in the industry as RWAs, which means representing an asset as a tradable entry on a blockchain. Injective says it reports more than $1 billion in tokenized RWA value onchain, and that cumulative RWA perpetual volume has passed $5.3 billion across asset classes including equities and commodities.
Earlier groundwork with regulators
In 2025 the company put forward a proposal for a time-based exemption for decentralised finance projects, giving early-stage protocols room to develop before the full weight of securities rules applied. In September 2026 the SEC introduced its Innovation Exemption, a move that signalled a regulator increasingly willing to make room for new financial technology.
What the meetings may signal
The meetings point toward a potential shift towards regulatory acceptance of DeFi, which could pave the way for institutional adoption. Whether that shift materialises will depend on decisions the company has not described.
Open questions
- What specific outcomes, if any, came out of the meetings?
- Will the Innovation Exemption be extended to more DeFi projects?